Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients
Clinical trial NCT06196918 · UNKNOWN
Trial details
- NCT number
- NCT06196918
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-08-31
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.